Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The sodium-iodide symporter.

C H Baker1, J C Morris

  • 1Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.

Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease.

The journal of prevention of Alzheimer's disease·2024
Same author

Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease.

medRxiv : the preprint server for health sciences·2023
Same author

Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2023
Same author

Editorial: How Will Aducanumab Approval Impact AD Research?

The journal of prevention of Alzheimer's disease·2021
Same author

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.

Endocrine-related cancer·2021
Same author

Editorial: Is Now the Time for Combination Therapies for Alzheimer Disease?

The journal of prevention of Alzheimer's disease·2019
Same journal

Boosting interleukin-10 production: therapeutic effects and mechanisms.

Current drug targets. Immune, endocrine and metabolic disorders·2005
Same journal

Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.

Current drug targets. Immune, endocrine and metabolic disorders·2005
Same journal

Hormonal effects on drug metabolism through the CYP system: perspectives on their potential significance in the era of pharmacogenomics.

Current drug targets. Immune, endocrine and metabolic disorders·2005
Same journal

Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation.

Current drug targets. Immune, endocrine and metabolic disorders·2005
Same journal

Failure of immune homeostasis -- the consequences of under and over reactivity.

Current drug targets. Immune, endocrine and metabolic disorders·2005
Same journal

The new immunosuppression: intervention at the dendritic cell-T-cell interface.

Current drug targets. Immune, endocrine and metabolic disorders·2005
See all related articles

The sodium-iodide symporter (NIS) protein transports iodide for thyroid function and disease treatment. Research now explores using NIS gene transfer for diagnosing and treating non-thyroidal cancers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The sodium-iodide symporter (NIS) is a plasma membrane protein crucial for iodide uptake.
  • NIS activity is fundamental for thyroid hormone synthesis and has established roles in thyroid imaging and therapy.

Purpose of the Study:

  • To review the established roles of NIS in thyroid physiology and disease.
  • To explore the emerging applications of NIS gene transfer in non-thyroidal cancers for diagnostic and therapeutic purposes.

Main Methods:

  • Literature review of NIS function and applications.
  • Analysis of research on NIS gene transfer strategies.

Main Results:

  • NIS mediates active iodide transport in thyroid and extra-thyroidal tissues.

Related Experiment Videos

  • Cloning and characterization of NIS have enabled its investigation in novel contexts.

    • Conclusions:

    • NIS is a versatile protein with significant implications for both thyroidal and non-thyroidal conditions.
    • Gene transfer of NIS holds promise for advancing the diagnosis and treatment of various cancers.